Opening bids totaling $64m have been submitted for bankrupt Teligent’s assets across the US and Canada, weeks after the injectables specialist entered Chapter 11 bankruptcy proceedings.
The bankrupt topicals and injectables specialist Teligent has found initial bidders for its assets a little over a month after entering Chapter 11 bankruptcy proceedings. Three stalking horse bidders have submitted three separate offers totaling $64m to snap up the US-based firm’s physical and intangible assets in the US and Canada.
With a bidding floor in place, Teligent is seeking to “promptly effectuate the sale transactions” subject to a “competitive bidding...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
